Returns | 1W : -0.8% , 1M : -6%,1Y : 8.8% |
LT :   |
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Peers & Returns | 1W | 1M | 1Y |
METROPOLIS HEALTHCARE LTD | -0.8% | -6% | 8.8% |
APOLLO HOSPITALS ENTERPRISE LTD | 4.5% | 16.8% | 72.5% |
DR LAL PATHLABS LTD | -3.9% | 2.3% | 39.6% |
FORTIS HEALTHCARE LTD | -0.6% | -2.6% | 2.7% |
ASTER DM HEALTHCARE LTD | -2.3% | -7.7% | -10.4% |
NARAYANA HRUDAYALAYA LTD | -6.9% | -1.8% | 33% |
THYROCARE TECHNOLOGIES LTD | -2% | -2.5% | 55.5% |
SHALBY LTD | 2.8% | -3% | 19.8% |
KOVAI MEDICAL CENTER & HOSPITAL LTD | 0.7% | -4% | 36.2% |
Ratio | Value |
---|---|
P/E P/B P/S |
77.85
P/E Calculated based on EPS of 25.15
[ Mar2020 - Consolidated Results ] 19.01
P/B Calculated based on Book Value of 102.99
[ Mar2020 - Consolidated Results ] 12.57
P/S Calculated based on Revenues of 796.238 Cr
[ TTM - Consolidated Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
71% 5013% 65% |
Pledged Shares |
5.44 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |